Delivery Order SPE2DB20D9103-SPE2DB25FE7D8
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,226.84 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, carries no set-aside designation. The contract represents a direct fulfillment order issued under DMS Pharmaceutical Group's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of YF-VAX 1 Dose Vials. The contract carries no set-aside designation and specifies an ultimate completion date of August 15, 2025, with performance to take place at the awardee's Park Ridge location. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,340.26 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of YF-VAX 1 Dose Vials. The contract, with an ultimate completion date of September 4, 2025, carries no set-aside designation and represents a direct delivery of pharmaceutical products to support federal healthcare needs. This delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $55,671 by the Defense Logistics Agency on June 24, 2025, for the supply of YF-VAX 1 Dose Vials. The contract utilizes firm fixed-price pricing with no set-aside designation and is scheduled for completion by July 16, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,226.84 by the Defense Logistics Agency on August 26, 2025, for the supply of YF-VAX 1 Dose Vials. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, carries no set-aside designation. The award leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for YF-VAX 1 dose vials with a ceiling value of $1,670.13. This firm fixed-price delivery order is scheduled for ultimate completion by September 25, 2025, and carries no set-aside designation. The award represents a specific delivery under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,670.13 by the Defense Logistics Agency (DLA) on August 21, 2025. The contract covers the supply of YF-VAX 1 Dose Vials, a yellow fever vaccine product, with an ultimate completion date of September 12, 2025. This delivery order was issued without a set-aside designation, and performance will be completed at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,567.10 by the Defense Logistics Agency (DLA) on July 10, 2025, for the supply of YF-VAX 1 dose vials. The contract carries a firm fixed-price structure with an ultimate completion date of July 31, 2025, and was awarded without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $33,402.60 by the Defense Logistics Agency for the supply of YF-VAX 1 Dose Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of May 15, 2025, and represents no specific set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $55,671.00 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of YF-VAX 1 Dose Vials. The contract carries a firm fixed price structure with an ultimate completion date of September 8, 2025, and was awarded without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
- SPE2DB20D9103Indefinite Delivery Contract
- SPE2DB20D9103-SPE2DB25FE7D8Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on August 7, 2025, for the supply of YF-VAX 1 Dose Vials. The contract utilizes firm fixed-price pricing with an ultimate completion date of August 28, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities. The award represents a discrete delivery of yellow fever vaccine vials to support medical supply requirements at military health facilities. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain through consistent contract performance across multiple product categories, ranging from specialty oncology medications to vaccines and biologics. The DLA's utilization of the SPE2DB indefinite delivery vehicle demonstrates the agency's reliance on DMS Pharmaceutical Group's capabilities to fulfill ongoing pharmaceutical distribution needs across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/7/25 |